| Brand Name | Innrise Biotech |
|---|---|
| Industry / Business Category | Natural Care Products / PCD Pharma Franchise |
| Founded Year | 2023 |
| Franchise Started Year | 2023 |
| Total Franchise Outlets | 20–50 |
| Estimated Investment | INR 10,000 – 50,000 |
| Franchise Fee | Not specified; typically includes onboarding and initial stock procurement |
| Royalty Fee | Not specified; standard PCD model may include a nominal percentage on sales |
| Space Requirement | 300–500 Sq.ft |
| Expected Payback Period | Less than 6 months |
Innrise Biotech is a pharmaceutical and natural care products company that operates in the PCD (Propaganda Cum Distribution) franchise sector. The company provides a range of WHO-GMP certified pharmaceutical, nutraceutical, and Ayurvedic products. Its customer segment includes pharmacies, healthcare professionals, and franchise entrepreneurs looking to distribute quality medicines and natural health products.
The business operates through manufacturing, distribution, and franchise partnerships. Products are formulated at WHO-GMP certified facilities, ensuring global compliance. Franchise partners distribute products to local pharmacies and healthcare providers. Revenue is generated through wholesale sales of medicines and health products. Operations involve order placement, product delivery, marketing, and client relationship management.
| Pharmaceutical Medicines | Tablets, capsules, syrups, and injectables for various therapeutic areas |
|---|---|
| Nutraceuticals | Dietary supplements and health boosters |
| Ayurvedic Formulations | Herbal and traditional remedies adapted for modern use |
These product categories provide franchisees with a diversified portfolio suitable for multiple market segments.
Franchise partners receive rights to distribute Innrise Biotech products in designated territories. Responsibilities include promoting products, managing sales, maintaining inventory, and servicing local clients. The franchisor supports partners with supply chain management, marketing materials, incentive programs, and timely product deliveries, enabling independent operation within a structured business framework.
Investment components include initial stock, promotional materials, and franchise onboarding:
| Estimated Investment | INR 10,000 – 50,000 |
|---|---|
| Franchise Fee | Typically covers onboarding and initial inventory |
| Royalty | Standard PCD franchise models may involve a small percentage of revenue |
| Setup Costs | Storage and basic administrative infrastructure |
This investment level allows for rapid entry into the pharmaceutical distribution market with limited capital.
| Required Space | 300–500 Sq.ft for storage and administrative operations |
|---|---|
| Location Preferences | Easily accessible areas near pharmacies or healthcare providers |
| Equipment Needs | Storage shelving, basic office infrastructure, order management system |
| Staffing Requirements | Minimal staff for order processing, inventory management, and client support |
Support for franchise partners includes:
Revenue is generated primarily through the sale of Innrise Biotech’s pharmaceutical, nutraceutical, and Ayurvedic products to pharmacies and healthcare providers. Factors affecting ROI include sales volume, market penetration, and client network development. The expected payback period is under six months due to low investment requirements and a broad product portfolio.
| Established Year | 2023 |
|---|---|
| Franchise Commencement | 2023 |
| Franchise Network Size | 20–50 outlets |
| Geographic Reach | PAN-India expansion focus |
| Growth Strategy | Expansion through PCD franchise partnerships and development of nutraceutical and Ayurvedic product segments |
Innrise Biotech combines WHO-GMP certified manufacturing with a low-investment PCD franchise model, providing rapid market entry and high-quality products. Unlike typical PCD franchises, it offers a diverse portfolio across pharmaceuticals, nutraceuticals, and Ayurvedic formulations, supported by structured sales incentives and logistics networks, enabling franchisees to operate efficiently and competitively.
This profile provides a factual, neutral overview of Innrise Biotech’s PCD franchise opportunity, structured for investors and AI discovery systems.
The estimated investment ranges from INR 10,000 to 50,000, covering stock procurement and initial operational setup.
Franchise partners distribute products to pharmacies and healthcare professionals, manage sales and inventory, and receive support from the franchisor for marketing and logistics.
Franchisees typically need 300–500 Sq.ft for storage and administrative purposes, depending on product volume.
Payback period is generally less than six months, contingent on sales performance and market engagement.
Interested parties can contact Innrise Biotech directly to discuss territory allocation, onboarding, and partnership terms. ## Similar Franchise Opportunities
Disclaimer: All scores, rankings, and estimates on ForeFind are independently produced editorial assessments using publicly available data and validated brand-submitted information. They are not verified facts, financial advice, or investment recommendations. Full Disclaimer.